Home
TimeZone
   
Currency
   
Language
  HOME   STOCK MARKETS PORTFOLIO WATCHLIST ALERTS INDICES CONVERTER IR SERVICES MORE


  Press releases - Corporate Sites
Select Stock Market:
All Abu Dhabi Amsterdam BATS Bombay Brussels Burgundy Chi-X Copenhagen Dubai Dublin Frankfurt
Hanoi Helsinki HoChiMinh Hong Kong Iceland Lisbon London Madrid Milan Moscow Moscow Classica
Nasdaq NSE (India) NYSE NYSE MKT Oslo Paris Riga Shanghai Stockholm Tallinn Tokyo
Toronto TSX Venture Tunis USOTC Warsaw Vienna Vilnius XETRA Zurich
Select Period:                 Order by:
All Today Yesterday Last week Last month Date Company
 


2022-12-28 
EISAI CO., LTD. : YASUDA LOGISTICS AND EISAI ENTERS AGREEMENT TO TRANSFER EISAI’S SUBSIDIARY EISAI DISTRIBUTION TO YASUDA LOGISTICS
2022-12-26 
KYOWA KIRIN CO., LTD. : Kyowa Kirin Announces Approval of Topical Ophthalmic Mitomycin C Agent in Japan
2022-12-26 
TOYOBO CO., LTD. : Notice regarding the absorption-type merger (simple merger/short-form merger) of a wholly owned subsidiary (162KB)
2022-12-23 
EISAI CO., LTD. : ARTICLE REGARDING SAFETY INFORMATION OF LECANEMAB REPORTED BY SCIENCEINSIDER
2022-12-23 
EISAI CO., LTD. : EISAI INITIATES BLA SUBMISSION OF DATA FOR LECANEMAB IN CHINA
2022-12-23 
DAIICHI SANKYO CO., LTD. : YESCARTA® NOW APPROVED IN JAPAN FOR INITIAL TREATMENT OF RELAPSED/REFRACTORY LARGE B-CELL LYMPHOMA(429.7KB)
2022-12-22 
EISAI CO., LTD. : Astellas, Eisai, Daiichi Sankyo and Takeda Agree to Collaborate to Reduce Environmental Burden in the Field of Pharmaceutical Packaging
2022-12-22 
DAIICHI SANKYO CO., LTD. : Astellas, Eisai, Daiichi Sankyo and Takeda Agree to Collaborate to Reduce Environmental Burden in the Field of Pharmaceutical Packaging(174KB)
2022-12-22 
KYOWA KIRIN CO., LTD. : Kyowa Kirin’s Ube Plant to Introduce Large-Scale Solar Power Generation System
2022-12-22 
KYOWA KIRIN CO., LTD. : Kyowa Kirin to Decide on Construction of a New Warehouse Building at its Takasaki Plant
2022-12-20 
DAIICHI SANKYO CO., LTD. : EZHARMIA® Launched in Japan as First Dual EZH1 and EZH2 Inhibitor Therapy for Patients with Adult T-Cell Leukemia- Lymphoma(217.3KB)PDF
2022-12-20 
EISAI CO., LTD. : EISAI TO DIVEST RIGHTS FOR ANTI-EPILEPTIC DRUG FYCOMPA® (perampanel) CIII IN UNITED STATES TO CATALYST PHARMACEUTICALS
2022-12-19 
DAIICHI SANKYO CO., LTD. : ENHERTU® Approved in the EU for Patients with Previously Treated HER2 Positive Advanced Gastric Cancer(230.8KB)
2022-12-19 
DAIICHI SANKYO CO., LTD. : ENHERTU® Recommended for Approval in the EU by CHMP for Patients with HER2 Low Metastatic Breast Cancer(222.5KB)
2022-12-16 
EISAI CO., LTD. : EISAI TERMINATES SPONSORED AMERICAN DEPOSITARY RECEIPT PROGRAM
2022-12-16 
TOYOTA TSUSHO CORPORATION : Toyota Tsusho Receives the 3rd CSA Award as a Company Recommended to People in their 20s for Creating the Human Capital of the Next Generation
2022-12-15 
EISAI CO., LTD. : EISAI AND WASHINGTON UNIVERSITY SCHOOL OF MEDICINE IN ST. LOUIS ENTER INTO COMPREHENSIVE RESEARCH COLLABORATION AGREEMENT AIMING TO CREATE NEW THERAPIES FOR NEURODEGENERATIVE DISEASES
2022-12-14 
AJINOMOTO CO., INC. : Ajinomoto Co., Inc. and MUFG Bank, Ltd. Conclude a Sustainability Linked Loan Agreement – Further Expanding Sustainable Finance Credit Lines
2022-12-13 
DAIICHI SANKYO CO., LTD. : ENHERTU® Supplemental New Drug Application Submitted in Japan for Patients with HER2 Mutant Metastatic Non-Small Cell Lung Cancer(248.5KB)PD
2022-12-13 
KYOWA KIRIN CO., LTD. : Kyowa Kirin Announces Lancet Publication of Phase 2b Study Results for Rocatinlimab (KHK4083/AMG 451) in Adult Patients with Moderate-to-Severe Atopic Dermatitis

   20      40      60      80    100    120    140    160    180    200    220    240    260    280    300    320    340    360    380    400  


   2024      2023      2022      2021      2020      2019      2018      2017      2016      2015      2014      2013      2012      2011      2010      2009      2008      2007      2006      2005      2004      2003      2002      2001      2000  
Back